CD47 is a potent Don’t eat me signal that enables cancer cells to evade immune surveillance and killing by innate immune cells, such as macrophages.

By using bispecific antibodies with a high affinity targeting arm (against a tumor-associated antigen, or TAA) and an anti CD47 arm of an optimized low affinity, the Don’t eat me signal is blocked selectively on TAA-positive cells, leading to the effective engulfment and degradation of tumor cells by macrophages (left-hand part of the video).

Due to the absence of a tumor-specific targeting arm, a monovalent anti CD47 bsAb is unable to bind and block CD47, with tumor cells that can resist the attack of macrophages (right-hand part of the video).

Images were taken with Nanolive’s 3D Cell Explorer at a rate of one image every 30 seconds.

For more information on fully human CD47-blocking κλ-bodies, please visit Light Chain Bioscience.

Download our Application Note

Read our latest news

Unlocking mitochondrial stress as a drug discovery readout

Feb 25, 2026 | News

Mitochondrial stress can act as an early warning biomarker for drug candidate toxicity and can appear hours before conventional cell viability results. Discover case study data demonstrating how mitochondrial stress can be used as an early warning biomarker for cytotoxicity prediction.

Trends in AI analysis for live cell imaging

Jan 19, 2026 | News

We review recent peer-reviewed studies that relied on noninvasive live-cell imaging to study immuno-oncology, cellular metabolism and disease progression in 2025, and share how advances in image analysis are supporting consistent interpretation of complex live-cell data in preclinical research.

2025’s Breakthroughs in AI-Driven Live Cell Analytics

Dec 19, 2025 | News

We look back at some of 2025’s major advances in AI-driven live cell analytics, from automated mitochondrial segmentation to dynamic EC50 profiling and next-generation T-cell insights. These breakthroughs bring deeper, label-free understanding to drug discovery and immuno-oncology.

More news